🇺🇸 FDA

Intelligence · Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs · EMA approved · by data quality · Page 20 of 39

  1. romiplostim

    NPLATE Amgen

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    B02BX04

  2. rotigotine

    NEUPRO

    TRANSDERMAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N04BC09

  3. rufinamide

    INOVELON

    ORAL FDA: approved · EMA: approved

    N03AF03

  4. ruxolitinib

    JAKAVI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    D11AH

  5. sacubitril

    ENTRESTO

    ORAL FDA: approved · EMA: approved

    C09DX04

  6. safinamide

    ARX-SAFINAMIDE Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    N04B

  7. sarilumab

    KEVZARA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    L04AC14

  8. satralizumab

    ENSPRYNG

    INJECTION FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    L04AC

  9. sebelipase alfa

    KANUMA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    A16

  10. secukinumab

    COSENTYX Novartis Pharmaceuticals

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L04AC10

  11. selexipag

    UPTRAVI Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    B01AC27

  12. selpercatinib

    RETEVMO

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EX22

  13. selumetinib

    KOSELUGO Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

  14. semaglutide

    OZEMPIC NovoThirteen

    SOLUTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    A10BJ06

  15. siltuximab

    SYLVANT Recordati Rare Diseases Australia Pty.

    INJECTION FDA: approved · EMA: approved · TGA: approved

    L04AC11

  16. siponimod

    MAYZENT Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L04

  17. sitagliptin

    JANUVIA Alphapharm Pty Ltd

    FILM COATED FDA: approved · EMA: approved · TGA: approved

    A10BH01

  18. sodium zirconium cyclosilicate

    LOKELMA

    ORAL FDA: approved · EMA: approved

    V03AE10

  19. somatropin

    GENOTROPIN GOQUICK Pfizer Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved

    H01AC01

  20. sotorasib

    LUMYKRAS

    ORAL FDA: approved · EMA: approved

    L01XX73

  21. stiripentol

    DIACOMIT Chiesi Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    N03AX17

  22. sugammadex

    BRIDION

    SOLUTION FDA: approved · EMA: approved

    V03AB35

  23. tafamidis

    VYNDAMAX Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    N07XX08

  24. tedizolid phosphate

    SIVEXTRO

    ORAL FDA: approved · EMA: approved

    J01XX11

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.